$AGLE, $AMGN, $DECK, $TSLA, $UBER, $VRTX
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of The Street’s Key analysts outlook for Key issues for Wednesday follows:
Aeglea BioTherapeutics Inc. (NASDAQAGLE) was started with a Buy rating and assigned a 20 target price at H.C. Wainwright. Shares trade in a 52-wk range of 6.31 – 12.00 and with a consensus price target at 18.20.
Amgen Inc. (NASDAQ:AMGN): Analysts started AMGN as Outperform and assigned a 208 price target at Credit Suisse.
Deckers Outdoor Corp. (NYSE:DECK) was raised to Buy from Neutral at Merrill Lynch. Shares trade in a 52-wk range of 101.62-159.75;
Tesla Inc. (NASDAQ:TSLA) its worst implied target ever. Morgan Stanley has lowered its worst-case scenario target to 10 from 97, but that is not its official target of course. The firm cited Tesla’s rising debt, geopolitical exposure and demand issues overseas. Morgan Stanley’s official price target remains at 230, and the firm has an Equal Weight rating. Shares trade in a 52-wk range of 195.25 – 387.46. Analysts have a consensus price target of 283.32.
Uber Technologies Inc. (NYSE:UBER); Analysts started UBER with an Equal Weight rating at a firm called Consumer Edge Research. Susquehanna started Uber with a Neutral rating. Shares have a consensus price target of 57.67.
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) was started as Outperform and assigned a 209 price target at Credit Suisse. The stock trades in a 52-wk range of 144.07 to 195.81. The stock’s consensus price target is 207.30.